Paloma Partners’s Momenta Pharmaceuticals, Inc. MNTA Stock Holding History

Paloma Partners’s Portfolio MNTA Stock Details MNTA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-82,654	Closed	-$4.34M	–	2488
2020 Q3	$4.34M	Buy	+82,654	New	+$3.42M	0.11%	176
2016 Q2	–	Sell	-19,185	Closed	-$177K	–	2409
2016 Q1	$177K	Buy	+19,185	New	+$206K	﹤0.01%	1716
2015 Q3	–	Sell	-72,270	Closed	-$1.65M	–	2064
2015 Q2	$1.65M	Buy	+72,270	New	+$1.44M	0.03%	529

Paloma Partners's MNTA Position: Q4 2020 in Review

Paloma Partners sold out of Momenta Pharmaceuticals, Inc. (MNTA) in Q4 2020, closing a stake of 82,654 shares — an estimated $4.34M sold.

Paloma Partners first reported a position in MNTA in Q2 2015 and held it in 3 quarters. The position peaked at $4.34M in Q3 2020. 0 funds tracked by Wall St. Rank hold MNTA as of Q4 2020.

Paloma Partners reported no remaining Momenta Pharmaceuticals, Inc. position as of Q4 2020 after selling out during the quarter.
Paloma Partners sold 82,654 Momenta Pharmaceuticals, Inc. shares in Q4 2020, an estimated $4.34M.
Paloma Partners first reported a position in Momenta Pharmaceuticals, Inc. in Q2 2015 and held it in 3 quarters.
Paloma Partners's Momenta Pharmaceuticals, Inc. position peaked at $4.34M in Q3 2020.
0 funds tracked by Wall St. Rank held Momenta Pharmaceuticals, Inc. as of Q4 2020.

Based on Paloma Partners's 13F filing for Q4 2020, filed 16 Feb 2021.